News
AstraZeneca’s Imfinzi receives European approval to treat patients with resectable muscle-invasive bladder cancer: Cambridge, UK Saturday, July 5, 2025, 09:00 Hrs [IST] AstraZen ...
The approval comes amid speculation that the big pharma company may switch its UK stock market listing to the US.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback